상세검색
검색어 입력 검색어는 최대 5개까지 추가하실 수 있습니다.
비밀번호 변경 안내
비밀번호를 변경하신 지 90일 이상 지났습니다.
개인정보 보호를 위해 비밀번호를 변경해 주세요.
비밀번호 변경 안내
비밀번호를 변경하신 지 90일 이상 지났습니다.
개인정보 보호를 위해 비밀번호를 변경해 주세요.
- 학술저널
- 대한진단검사의학회
- Annals of Laboratory Medicine
- Annals of Laboratory Medicine 제30권 제5호
- 2010
- 474 - 476 (3 pages)
- KCI등재
발행기관의 요청으로 개인이 구매하실 수 없습니다.
초록
JAK2 V617F and MPL W515L/K mutations have been reported in approximately 50% and 5% of the patients with essential thrombocythemia (ET), respectively. We investigated the frequency of MPL W515L/K mutations in a series of consecutive patients with ET and post-essential thrombocythemia myelofibrosis (post-ET MF). The study subjects were 63 patients diagnosed either with ET (N=59) or post-ET MF (N=4) at our institution between June 2006 and February 2010. Among them, 35 (55.6%) had the JAK2 V617F mutation. MPL W515L/K mutations were detected by direct sequencing analyses of exon 10, and 2 patients were found to harbor the following MPL mutations: W515L in 1 patient with ET and W515K in 1 patient with post-ET MF. Neither of the patients had the JAK2 V617F mutation. The frequencies of the MPL W515L/K and JAK2 V617F-negative mutations in our subjects with ET/post-ET MF were 3.2% (2/63) and 7.1% (2/28), respectively. This is the first study to report the frequency of JAK2 V617F and MPL W515L/K mutations in Korean patients with ET/post-ET MF. (Korean J Lab Med 2010;30:474-6)
목차
참고문헌(8)
-
1.
-
2.
-
3.
-
4.
-
5.
추천 논문(5)
-
1.
-
2.
-
3.
-
4.
-
5.
리뷰(0)
도움이 되었어요.0
도움이 안되었어요.0
도움이 되었어요.0
도움이 안되었어요.0
